dithionitrobenzoic acid has been researched along with dalcetrapib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, N; Matsushita, M; Miyai, A; Nakajima, K; Nakano, T; Okamoto, H; Sasase, T | 1 |
1 other study(ies) available for dithionitrobenzoic acid and dalcetrapib
| Article | Year |
|---|---|
Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
Topics: Amides; Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol; Cholesterol Ester Transfer Proteins; Dithionitrobenzoic Acid; Enzyme Inhibitors; Esters; Female; Humans; In Vitro Techniques; Lipoproteins; Male; Phosphatidylcholine-Sterol O-Acyltransferase; Recombinant Proteins; Sulfhydryl Compounds; Triglycerides | 2007 |